Product ID: UCMIG35I2134
Radiopharmaceuticals Market Size, Share, Growth Analysis, By Type(Diagnostic Nuclear Medicine, SPECT Radiopharmaceuticals), By Application(Diagnostic Applications, SPECT Applications), By Procedural Volume Assessment(Diagnostic Procedures, Therapeutic Procedures), By Source(Nuclear Reactors, Cyclotrons), By End User(Hospitals, Ambulatory Surgical Centers), By Regional(North America, Europe) - Industry Forecast 2024-2031
Report ID:
UCMIG35I2134 |
Region:
Global |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
Radiopharmaceuticals Market Competitive Landscape
To understand the competitive landscape, we are analyzing key Radiopharmaceuticals Market vendors in the market. To understand the competitive rivalry, we are comparing the revenue, expenses, resources, product portfolio, region coverage, market share, key initiatives, product launches, and any news related to the Radiopharmaceuticals Market.
To validate our hypothesis and validate our findings on the market ecosystem, we are also conducting a detailed porter's five forces analysis. Competitive Rivalry, Supplier Power, Buyer Power, Threat of Substitution, and Threat of New Entry each force is analyzed by various parameters governing those forces.
Key Players Covered in the Report:
- Cardinal Health Inc.
- GE Healthcare
- IBA Group
- Lantheus Medical Imaging
- Covidien Plc
- Positron Corporation
- NTP Radioisotopes Pty Ltd
Radiopharmaceuticals Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
